AU/NZ

Revolutionary
ExoTMS Technology
for Mental Wellness

By BTL: as seen in

50% of Aesthetic Patients Struggle
With Mental Wellness. 1

EXOMIND is a non-invasive brain stimulation system developed by BTL for clinics looking to expand into evidence based mental wellness treatments.

EXOMIND’s patented ExoTMS technology is built on the foundation of Transcranial Magnetic Stimulation, a well-established and noninvasive therapy that has been studied for decades in the treatment of various psychological conditions.

Introducing EXOMIND

EXOMIND’s patented ExoTMS technology delivers targeted electromagnetic stimulation to key areas of the brain involved in emotional regulation, cognitive function, and self-control.

By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity for improved mental wellness.

As a result, patients not only benefit from mood elevation but also feel more in control of their lives.

How EXOMIND Improves Mental Wellness

Experienced Improved
Sleep Onset(2)

Felt Less
Stressed(2)

Felt More Energised And In
Better Mood(2)

Experienced Improved
Sleep Onset(2)

Clinics can now bridge the gap between aesthetics and mental wellbeing, all within an efficient 30-minute walk-in/walk-out session.

Why Clinics Are Offering EXOMIND.

Expand your clinic’s reach by offering mental wellness services alongside aesthetic treatments.

Built for Providers. Designed for Growth.

EXOMIND is part of the BTL portfolio, trusted by leading clinics around the world for over 30 years.

BTL supports practices with technologies that are:

Explore the BTL Technology Portfolio

Alongside EXOMIND, BTL offers a suite of non-invasive systems to help clinics diversify their service offering:

Leading Noninvasive Face Lift Technology

Muscle building and fat reduction

Radiofrequency and ultrasound for skin regeneration and fat reduction

Pelvic floor therapy for incontinence and sexual health

Each technology is engineered for measurable results, efficient workflows, and commercial success.

Why Partner with BTL?

Our team works closely with clinics to ensure seamless implementation and business results.

This product is not available for purchase by the general public.
The findings showed consistent outcomes across the clinical studies.
Patient results and experience may vary.

Become a BTL Partner today.

Elevate your practice offering with award-winning devices.

BTL partners with clinics committed to clinical excellence and innovation.

Evidence based technologies with global clinical adoption

Comprehensive training and marketing support

Dedicated technical service and ongoing partnership

Devices registered and compliant in Australia and New Zealand

Fill in your details and our team will be in touch to discuss your goals and product suitability.

Request BTL Product Information

Country(Required)
Interested in(Required)
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

By filling the form I am aware that BTL contacts me to keep me informed about news of BTL Group and about its products and services.

Contact BTL Australia

Address:
Administration & Service:
Unit 5 / 10 Enterprise Close
West Gosford NSW 2250

Showroom:
Suite 2.05, Level 2, Building D, Talavera Corporate Center,
12-24 RTalavera Road, Macquarie Park NSW 2113

Email: info@btlmed.com.au
Gareth Pepper, Sales Director +61 435 769 639

Contact BTL New Zealand

Address:
130 St Georges Bay Rd, Parnell,
Auckland 1052

Email: ehab@btlmed.nz / info@btlmed.nz
Ehab Jirgis , Business Development Manager +64 21 284 2628

Clinical references: 1. Viegas, F. & Figueiredo, I. & Ferreira, Filipa & Lourenço, A.. (2021). Mental health conditions in people searching for aesthetic treatments: The importance of early detection.
European Psychiatry. 64. S458-S458. 10.1192/j.eurpsy.2021.1224. 2. Michelle Dees, Yael Halaas, JD McCoy.
ExoTMS™ Technology: A Novel Breakthrough in Transcranial
Magnetic Stimulation for Enhancing Mental Well-Being.
Journal of Psychiatry and Psychiatric Disorders. 9 (2025):
245-254